{"id":35,"date":"2024-11-27T07:32:20","date_gmt":"2024-11-27T05:32:20","guid":{"rendered":"https:\/\/www.ipsen.com\/middleeast\/?page_id=35"},"modified":"2025-10-24T13:13:30","modified_gmt":"2025-10-24T11:13:30","slug":"history","status":"publish","type":"page","link":"https:\/\/www.ipsen.com\/uae-gulf\/company\/history\/","title":{"rendered":"History"},"content":{"rendered":"    <section class=\"sub-page-banner bg-img\" style=\"background-image:url(https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/18\/2025\/10\/07055253\/Company-History.jpg)\">\n        <div class=\"container content-sec\">\n            <nav aria-label=\"breadcrumb\">\n            <ol class=\"breadcrumb\">\n                <li class=\"breadcrumb-item\"><a href=\"https:\/\/www.ipsen.com\/uae-gulf\">Home<\/a><\/li><li class=\"breadcrumb-item visible\"><a href=\"https:\/\/www.ipsen.com\/uae-gulf\/company\/\">Company<\/a><\/li><li class=\"breadcrumb-item active\"><a class=\"link-pointer-events-none\" href=\"#\" aria-current=\"page\">History<\/a><\/li><\/ol>\n            <\/nav>            <h1 class=\"visible\">History<\/h1>\n            <p class=\"visible\">95+ years of expertise working in areas of high unmet medical need. <\/p>\n        <\/div>\n    <\/section>\n\n\n    <section class=\"title-text \">\n        <div class=\"container\">\n            <div class=\"title-text-inner\" style=\"background-color:#EDEBE4;\">\n\n                <!-- If heading is enabled then it's visible -->\n                <div class=\"text-head-dash hidden\">\n                <h3 class=\"heading-three\" role=\"heading\" aria-level=\"2\">\n                                            <\/h3>\n                <\/div>\n               \n                <!-- If description is enabled then it's visible -->\n                <div class=\"text-parbase visible\">\n                    <p>Founded in 1929 as a family business, Ipsen has almost a century of experience and expertise and focuses in three therapeutic areas: Oncology, Rare Disease and Neuroscience.<\/p>\n                <\/div>\n\n                <!-- If button is enabled then it's visible -->\n                                        <div class=\"btn-txt\">\n                            <a \n                                aria-label=\"\" \n                                class=\"btn-link section-btn cta-visible\"  \n                                role=\"link\"\n                                href=\"https:\/\/www.ipsen.com\/uae-gulf\/company\/\" target=\"_self\">\n                                Learn more                            <\/a>\n                        <\/div>\n                \n            <\/div>\n        <\/div>\n    <\/section>\n\n\n\u00a0\n<!-- Ipsen History Timeline Start -->\n<section class=\"history-pipeline\" >\n\t<div class=\"container\">\n  \t\t<h3 class=\"history-title heading-three\">\n\t\t\tIpsen\u2019s Milestones\t\t<\/h3>\n  \t\t\t\t\t<input type=\"hidden\" class=\"pagenum\" value=\"1\" \/>\n\t\t\t<input type=\"hidden\" class=\"total-page\" id=\"total_page\" value=\"20\" \/>\n\t\t\t<input type=\"hidden\" class=\"post_id\" id=\"post_id\" value=\"35\" \/>\n\t\t\t<input type=\"hidden\" class=\"tot_load_post\" id=\"tot_load_post\" value=\"\" \/>\n\t\t\t<input type=\"hidden\" class=\"start_inn\" id=\"start_inn\" value=\"5\" \/>\n\t\t\t\t  \t\t\t<div class=\"timeline-filter\">\n\t  \t\t\tPeriod \n\t\t\t\t<select aria-label=\"period\" name=\"period\" id=\"period\" onChange=\"getyears()\" tabindex=\"0\">\t\t\t\t\t\t\t\t\n\t\t\t\t\t<option value=\"all\">All<\/option>\n\t\t\t\t\t\t\t\t\t\t\t<option value=\"2023\">2023<\/option>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<option value=\"2022\">2022<\/option>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<option value=\"2019\">2019<\/option>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<option value=\"2017\">2017<\/option>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<option value=\"2015\">2015<\/option>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<option value=\"2014\">2014<\/option>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<option value=\"2013\">2013<\/option>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<option value=\"2011\">2011<\/option>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<option value=\"2007\">2007<\/option>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<option value=\"2005\">2005<\/option>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<option value=\"2004\">2004<\/option>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<option value=\"2003\">2003<\/option>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<option value=\"2000\">2000<\/option>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<option value=\"1990\">1990<\/option>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<option value=\"1980\">1980<\/option>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<option value=\"1970\">1970<\/option>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<option value=\"1960\">1960<\/option>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<option value=\"1950\">1950<\/option>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<option value=\"1929\">1929<\/option>\n\t\t\t\t\t\t\t\t\t\t\t<\/select>\n  \t\t\t<\/div>\n  \t\t  \t\t<div id=\"loading\"\n\t\t  style=\"background-image: url('https:\/\/www.ipsen.com\/uae-gulf\/wp-content\/themes\/ipsen-main\/dist\/images\/loader.png');z-index: 9999;display: none;position: absolute;left: 50%;\">\n\t  \t<\/div>\n\t\t<div class=\"main-timeline\">\t\n   \t\t\t\t\t<div>\n\t\t\t<div class=\"custom-year-right\"  >\n\t\t\t<i class=\"far fa-clock\" aria-hidden=\"true\"><\/i> \n\t\t\t\t\t<h5>March 2023 <\/h5>\n\t\t\t<\/div>\n\t\t\t<div class=\"timeline left-2\">\n\t\t\t\t<div class=\"card-history\">\n\t\t\t\t\t\t\t\t\t<img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/18\/2025\/01\/08110303\/01-C_March-2023_Ipsen-acquires-Albireo_1.jpeg\" class=\"card-img-top\" alt=\"\">\n\t\t\t\t\t\t\t\t<div class=\"card-body\">                   \n\t\t\t\t\t<div class=\"mb-0\"><p><p><strong>Ipsen acquires Albireo<\/strong><\/p>\n<p>Ipsen acquires rare liver disease specialist Albireo, bringing into its portfolio Bylvay<sup>\u00ae<\/sup> (odevixibat), a non-systemic ileal bile acid transport inhibitor for the treatment of pediatric patients with pruritus in progressive familial intrahepatic cholestasis (PFIC).<\/p>\n<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>              \n\t\t\t<\/div>        \n\t\t<\/div>\n\t\t\t\t\t<div>\n\t\t\t<div class=\"custom-year-left\"  >\n\t\t\t<i class=\"far fa-clock\" aria-hidden=\"true\"><\/i> \n\t\t\t\t\t<h5>August 2022 <\/h5>\n\t\t\t<\/div>\n\t\t\t<div class=\"timeline right-2\">\n\t\t\t\t<div class=\"card-history\">\n\t\t\t\t\t\t\t\t\t<img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/18\/2025\/01\/08110316\/01-C_August-2022_Epizyme_acquired.jpeg\" class=\"card-img-top\" alt=\"\">\n\t\t\t\t\t\t\t\t<div class=\"card-body\">                   \n\t\t\t\t\t<div class=\"mb-0\"><p><p><strong>Epizyme acquired<\/strong><\/p>\n<p>Ipsen successfully completed the acquisition of Epizyme and its lead medicine, Tazverik<sup>\u00ae<\/sup> (tazemetostat), a first-in-class, chemotherapy-free EZH2a inhibitor for adults with relapsed or refractory follicular lymphoma (FL), which was granted Accelerated Approval by the U.S. Food and Drug Administration (FDA) in 2020. As part of the transaction, Ipsen also acquired Epizyme\u2019s first-in-class, oral SETD2 inhibitor development candidate.<\/p>\n<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>              \n\t\t\t<\/div>        \n\t\t<\/div>\n\t\t\t\t\t<div>\n\t\t\t<div class=\"custom-year-right\"  >\n\t\t\t<i class=\"far fa-clock\" aria-hidden=\"true\"><\/i> \n\t\t\t\t\t<h5>July 2022 <\/h5>\n\t\t\t<\/div>\n\t\t\t<div class=\"timeline left-2\">\n\t\t\t\t<div class=\"card-history\">\n\t\t\t\t\t\t\t\t\t<img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/18\/2025\/01\/08110328\/01-C_July-2022_Consumer-HealthCare-divested.jpeg\" class=\"card-img-top\" alt=\"\">\n\t\t\t\t\t\t\t\t<div class=\"card-body\">                   \n\t\t\t\t\t<div class=\"mb-0\"><p><p><strong>Consumer HealthCare divested<\/strong><\/p>\n<p>In February 2022, Ipsen announced the proposed sale of the Consumer HealthCare (CHC) division after entering into exclusive negotiations with the French laboratory Mayoly Spindler. In July, Ipsen completed the divestment of the CHC business to Mayoly Spindler.<\/p>\n<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>              \n\t\t\t<\/div>        \n\t\t<\/div>\n\t\t\t\t\t<div>\n\t\t\t<div class=\"custom-year-left\"  >\n\t\t\t<i class=\"far fa-clock\" aria-hidden=\"true\"><\/i> \n\t\t\t\t\t<h5> 2019 <\/h5>\n\t\t\t<\/div>\n\t\t\t<div class=\"timeline right-2\">\n\t\t\t\t<div class=\"card-history\">\n\t\t\t\t\t\t\t\t\t<img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/18\/2025\/01\/08110344\/01-C_2019_Boosting-Ipsen-s-capacities-in-Rare-Disease.jpeg\" class=\"card-img-top\" alt=\"\">\n\t\t\t\t\t\t\t\t<div class=\"card-body\">                   \n\t\t\t\t\t<div class=\"mb-0\"><p><p><strong>Boosting Ipsen\u2019s capacities in Rare Disease<\/strong><\/p>\n<p>Ipsen acquired Montreal-based Clementia Pharmaceuticals, specializing in rare bone diseases, Clementia brought a drug candidate, palovarotene, to Ipsen for a rare genetic disease, fibrodysplasia ossificans progressiva (FOP).<\/p>\n<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>              \n\t\t\t<\/div>        \n\t\t<\/div>\n\t\t\t\t\t<div>\n\t\t\t<div class=\"custom-year-right\"  >\n\t\t\t<i class=\"far fa-clock\" aria-hidden=\"true\"><\/i> \n\t\t\t\t\t<h5> 2017 <\/h5>\n\t\t\t<\/div>\n\t\t\t<div class=\"timeline left-2\">\n\t\t\t\t<div class=\"card-history\">\n\t\t\t\t\t\t\t\t\t<img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/18\/2025\/01\/08110359\/01-C_2019_Treatment-approvals-and-asset-acquisitions.jpeg\" class=\"card-img-top\" alt=\"\">\n\t\t\t\t\t\t\t\t<div class=\"card-body\">                   \n\t\t\t\t\t<div class=\"mb-0\"><p><p><strong>Treatment approvals and asset acquisitions<\/strong><\/p>\n<p>The Dysport Injection was approved in the United States for the treatment of lower limb spasticity in children aged two years and older. Ipsen also licensed cabozantinib from Exelixis, which received marketing authorization the same year for the second-line treatment of advanced renal cell carcinoma. In January the following year, Ipsen announced the acquisition of certain assets of Merrimack Pharmaceuticals, including Onivyde<sup>\u00ae<\/sup>, for the treatment of pancreatic and ovarian cancer.<\/p>\n<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>              \n\t\t\t<\/div>        \n\t\t<\/div>\n\t\t\t\t\t\n\t<\/div>\t\n\t\t\t\t\t<div class=\"loader-more\" style=\"text-align:center\" onClick=\"getresult()\">\n\t\t\tScroll to load more\t\t\t<img decoding=\"async\" class=\"loader-img\" src=\"https:\/\/www.ipsen.com\/uae-gulf\/wp-content\/themes\/ipsen-main\/dist\/images\/loader.png\" alt=\"loader\" title=\"loader\">\n\t\t<\/div>\n\t\t   <\/div>\n<\/section>\n<!-- Ipsen History Timeline End -->\n\n\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":31,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-35","page","type-page","status-publish","hentry","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>History - UAE &amp; Gulf<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ipsen.com\/uae-gulf\/company\/history\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"History - UAE &amp; Gulf\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ipsen.com\/uae-gulf\/company\/history\/\" \/>\n<meta property=\"og:site_name\" content=\"UAE &amp; Gulf\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-24T11:13:30+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ipsen.com\/uae-gulf\/company\/history\/\",\"url\":\"https:\/\/www.ipsen.com\/uae-gulf\/company\/history\/\",\"name\":\"History - UAE &amp; Gulf\",\"isPartOf\":{\"@id\":\"https:\/\/www.ipsen.com\/uae-gulf\/#website\"},\"datePublished\":\"2024-11-27T05:32:20+00:00\",\"dateModified\":\"2025-10-24T11:13:30+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ipsen.com\/uae-gulf\/company\/history\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ipsen.com\/uae-gulf\/company\/history\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ipsen.com\/uae-gulf\/company\/history\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ipsen.com\/uae-gulf\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Company\",\"item\":\"https:\/\/www.ipsen.com\/uae-gulf\/company\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"History\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ipsen.com\/uae-gulf\/#website\",\"url\":\"https:\/\/www.ipsen.com\/uae-gulf\/\",\"name\":\"Middle East\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.ipsen.com\/uae-gulf\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ipsen.com\/uae-gulf\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ipsen.com\/uae-gulf\/#organization\",\"name\":\"Middle East\",\"url\":\"https:\/\/www.ipsen.com\/uae-gulf\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ipsen.com\/uae-gulf\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/18\/2024\/10\/16095804\/Logo-Ipsen-new.svg\",\"contentUrl\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/18\/2024\/10\/16095804\/Logo-Ipsen-new.svg\",\"caption\":\"Middle East\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/uae-gulf\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"History - UAE &amp; Gulf","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ipsen.com\/uae-gulf\/company\/history\/","og_locale":"en_US","og_type":"article","og_title":"History - UAE &amp; Gulf","og_url":"https:\/\/www.ipsen.com\/uae-gulf\/company\/history\/","og_site_name":"UAE &amp; Gulf","article_modified_time":"2025-10-24T11:13:30+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ipsen.com\/uae-gulf\/company\/history\/","url":"https:\/\/www.ipsen.com\/uae-gulf\/company\/history\/","name":"History - UAE &amp; Gulf","isPartOf":{"@id":"https:\/\/www.ipsen.com\/uae-gulf\/#website"},"datePublished":"2024-11-27T05:32:20+00:00","dateModified":"2025-10-24T11:13:30+00:00","breadcrumb":{"@id":"https:\/\/www.ipsen.com\/uae-gulf\/company\/history\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ipsen.com\/uae-gulf\/company\/history\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ipsen.com\/uae-gulf\/company\/history\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ipsen.com\/uae-gulf\/"},{"@type":"ListItem","position":2,"name":"Company","item":"https:\/\/www.ipsen.com\/uae-gulf\/company\/"},{"@type":"ListItem","position":3,"name":"History"}]},{"@type":"WebSite","@id":"https:\/\/www.ipsen.com\/uae-gulf\/#website","url":"https:\/\/www.ipsen.com\/uae-gulf\/","name":"Middle East","description":"","publisher":{"@id":"https:\/\/www.ipsen.com\/uae-gulf\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ipsen.com\/uae-gulf\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.ipsen.com\/uae-gulf\/#organization","name":"Middle East","url":"https:\/\/www.ipsen.com\/uae-gulf\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ipsen.com\/uae-gulf\/#\/schema\/logo\/image\/","url":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/18\/2024\/10\/16095804\/Logo-Ipsen-new.svg","contentUrl":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/18\/2024\/10\/16095804\/Logo-Ipsen-new.svg","caption":"Middle East"},"image":{"@id":"https:\/\/www.ipsen.com\/uae-gulf\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.ipsen.com\/uae-gulf\/wp-json\/wp\/v2\/pages\/35","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipsen.com\/uae-gulf\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.ipsen.com\/uae-gulf\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/uae-gulf\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/uae-gulf\/wp-json\/wp\/v2\/comments?post=35"}],"version-history":[{"count":10,"href":"https:\/\/www.ipsen.com\/uae-gulf\/wp-json\/wp\/v2\/pages\/35\/revisions"}],"predecessor-version":[{"id":85133,"href":"https:\/\/www.ipsen.com\/uae-gulf\/wp-json\/wp\/v2\/pages\/35\/revisions\/85133"}],"up":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/uae-gulf\/wp-json\/wp\/v2\/pages\/31"}],"wp:attachment":[{"href":"https:\/\/www.ipsen.com\/uae-gulf\/wp-json\/wp\/v2\/media?parent=35"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}